GSK2140944 capsule

DRUG2 trials

Sponsors

GlaxoSmithKline

Conditions

Infections, BacterialInfections, Respiratory Tract

Phase 1

A Study to Investigate the Recovery, Excretion and Pharmacokinetics of [14C]-GSK2140944 Administered as a Single Intravenous and Single Oral Dose to Healthy Adult Male Subjects

CompletedNCT02000765

GlaxoSmithKlineInfections, Respiratory Tract

Start: 2013-11-08End: 2013-11-30Updated: 2017-07-13

Relative Bioavailability, Safety, Tolerability, Pharmacokinetics (PK) and Food Effect Study of GSK2140944 in Healthy Subjects

CompletedNCT02045849

GlaxoSmithKlineInfections, Bacterial

Start: 2014-01-28End: 2014-08-21Updated: 2017-07-13

Related Papers

Pharmacokinetics, safety, and tolerability of gepotidacin administered as single or repeat ascending doses, in healthy adults and elderly subjects

Clinical and Translational Science2022-06-306 citations